You are here: Home » PTI Stories » National » News
Business Standard

Use of statins reduces mortality, stroke risk in dementia patients: Study

Health Medical Pharma

Press Trust of India  |  London 

The use of statins is significantly associated with a reduction in the risk of mortality in dementia patients, according to a study.

The study, which analysed 44,920 Swedish dementia patients between 2008 and 2015, found users of statins had a 22 per cent lower risk of all-cause death compared to matched non-users.

"Survival in patients in dementia is variable, and previous studies have identified many factors associated with survival and risk of stroke in these patients," said Bojana Petek from the University Medical Center Ljubljana in Slovenia.

"However, the effect of statins on these two outcomes is not clear. The aim of this study was to analyse the association between the use of statins on the risk of death and stroke in patients diagnosed with dementia," Petek said.

The research, which was presented at 5th European Academy of Neurology (EAN) Congress, also demonstrated that statin users had a 23 per cent reduction in the risk of stroke, which is three times more likely in patients with mild dementia and seven times more likely in those with severe dementia.

The protective effect of statins on survival were strong for patients younger than 75 years (27 per cent reduction) and in men (2 per cent reduction) but women and older patients also benefited (17 per cent and 20 per cent reduction, respectively).

Patients with vascular dementia -- the second most common type of dementia after Alzheimer's disease -- also saw a 29 per cent lower mortality risk, according to the study.

"This is a cohort study, which means patients were not randomized to a treatment like they would be in a clinical trial. For this reason, we can only show an association, and not definitely prove that statins caused this decline in mortality," said Dr Sara Garcia-Ptacek from the Karolinska Institutet in Sweden.

"However, our results are encouraging and suggest that patients with dementia benefit from statins to a similar extent than patients without dementia," she added.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, July 01 2019. 16:30 IST